查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1827850

植入式醫療設備市場（按產品類型、材料、應用和最終用戶分類）—2025-2032 年全球預測

Implantable Medical Device Market by Product Type, Material, Application, End User - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 185 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，植入式醫療設備市場規模將成長至 1,465.6 億美元，複合年成長率為 7.36%。

主要市場統計數據
基準年2024年 829.9億美元
預計2025年 887.8億美元
預測年份：2032年 1465.6億美元
複合年成長率（%） 7.36%

一份全面的策略介紹，概述了意圖、範圍、相關人員的優先事項和關鍵主題，以指南有關植入式設備的業務決策

本執行摘要以結構化、主導的觀點，探討植入式醫療設備領域，旨在為董事會層面的策略制定、產品開發重點和公司規劃提供參考。摘要概述了影響決策的關鍵主題：技術整合、監管複雜性、採購動態和不斷發展的臨床路徑，並強調了創新與實際部署挑戰之間的相互關係。引言部分旨在幫助讀者熟悉報告的分析方法，明確主要讀者，並概述如何利用研究結果來支持近期專案選擇和長期投資組合合理化。

導言部分透過提出清晰的問題並明確所要應對的策略挑戰，建立了通用的解讀基準。本書重點闡述了臨床結果、供應鏈結構和報銷環境將如何決定植入式器械的採用軌跡。因此，讀者將獲得精準的指導，將技術性能和材料選擇與機構採購行為和臨床醫生的接受度聯繫起來，從而能夠在臨床、監管和商業職能部門進行更有針對性的後續跟進。

快速變化和技術採用動態塑造植入式醫療創新的臨床、監管方法和供應鏈彈性

在技​​術創新、監管審查力度加大以及臨床醫生期望不斷變化等因素的推動下，植入式醫療設備的格局正在迅速變化。先進材料和微型電子設備正在催生出集感測、驅動和連接功能於一體的新型設備，而影像處理和外科技術的進步則正在拓展可能的干涉範圍。同時，監管機構也日益重視上市後監管、網路安全要求和人為因素檢驗，凸顯了強而有力的臨床證據和生命週期管理的重要性。

供應鏈動態正朝著更具彈性和地理多樣性的方向轉變，這迫使製造商重新思考籌資策略，並加強與委託製造製造商和專業供應商的合作。付款方和供應商生態系統要求更強力的價值證明和以患者為中心的成果，這正在影響產品設計和商業化計劃。這些轉變的整合意味著公司必須比以往任何時候都更加緊密地協調其研發、監管和市場進入職能，並採用更敏捷的營運模式，將技術進步轉化為持續的臨床應用和永續的商業性回報。

評估2025年美國關稅對製造業、籌資策略、跨國合作及醫療設備供應鏈的累積影響

2025年影響跨境貿易和關稅制度的政策變化將對植入式設備製造商、供應商和採購商產生重大影響。關稅調整正在改變全球供應鏈的成本結構，迫使採購團隊重新評估採購區域，並評估近岸外包和區域採購作為傳統集中模式的替代方案。這些決策將影響供應商談判、庫存策略，以及在投資本地製造能力和維護全球供應商關係之間的平衡。

因此，企業正在重新審視其總到岸成本分析和供應商風險狀況，以了解其對產品供應和生產前置作業時間的累積影響。臨床服務提供者也正在重新審視競標週期和設備選擇標準，以降低價格波動和潛在中斷帶來的風險。除了直接的營運變化外，關稅主導的轉變還促使製造商和醫療系統之間進行策略合作，包括簽訂多年期合約和聯合規劃產能緩衝。透過這些因應措施，相關人員旨在維持臨床的連續性，同時使商業模式適應更複雜的國際貿易環境。

關鍵細分洞察揭示了醫療保健服務環境中產品、材料組合、臨床應用和最終用戶設定的需求模式差異

市場區隔洞察揭示了產品類型、材料、應用和最終用戶環境的需求概況和開發優先級，從而為產品組合和上市策略提供資訊。產品層面的差異化非常重要。心臟植入（如去心房顫動和心律調節器）需要強調嚴格可靠性、長期遠端檢測、耐用性和遠端監控的監管途徑。乳房植入和臉部植入等美容植入優先考慮生物相容性材料和美學效果，這取決於患者的偏好和外科醫生的技術。牙科植入直接與修復工作流程交互，需要精確的材料和表面工程來增強骨整合。神經植入需要超低延遲電子設備和密封包裝來支援精細的神經應用。眼科植入必須符合微尺度公差和眼科安全標準。材料細分（陶瓷、金屬和聚合物）決定了耐磨性、耐腐蝕性、影像相容性和組織反應方面的性能權衡，從而影響設備選擇和臨床通訊協定。基於應用（例如心臟病學、整形外科、牙科、神經內科、整形外科）的細分，進一步指導了臨床證據的開發和報銷定位。最終使用者（門診手術中心、診所和醫院）擁有不同的採購週期、手術量和資金約束，這些因素決定了他們的採購管道和服務支援需求。整合這些細分視角，可以更精細地確定產品與市場的契合度、確定臨床試驗的優先級，並客製化反映每個醫療環境營運現狀的商業模式。

戰略區域洞察，重點關注美洲、歐洲、中東和非洲以及亞太市場的需求促進因素、監管細節和採用障礙

區域差異持續對植入式器械的監管流程、報銷途徑和實施時間表產生重大影響。美洲市場擁有成熟的臨床生態系統、完善的報銷框架和較高的手術量，對能夠展現明確臨床和經濟價值的高階醫療設備極具吸引力。相較之下，歐洲、中東和非洲的監管格局則呈現出差異化，區域協調舉措和國家特定的報銷流程並存，這既為差異化的參與策略創造了機會，也帶來了證據一致性方面的挑戰。亞太地區基礎設施擴張迅速，訓練有素的專家數量不斷增加，政府主導的醫療能力提升舉措也為新外科技術的快速應用提供了支持，儘管價格敏感度較高，且監管時間表各不相同。

這些區域動態對監管申報、上市後預期和商業性優先排序具有實際意義。公司通常會根據報銷準備和臨床領軍人才的可用性來安排上市順序，同時根據區域採購標準客製化通訊和定價策略。策略性區域夥伴關係和適應性上市策略對於平衡全球產品標準化與本地客製化需求至關重要，從而實現擴充性且有效的區域推廣計畫。

競爭對手層面的洞察，重點在於領先設備製造商的策略組合、合作夥伴網路、智慧財產權重點和營運重點

植入式器械生態系統中的主要企業透過專注於生命週期管理和臨床證據產生的策略性投資組合選擇、合作夥伴關係和業務投資，脫穎而出。一些製造商正在深化其在相關服務產品方面的能力，例如遠端監控平台、上市後監測數據分析以及外科醫生培訓解決方案，以提供能夠改善患者預後並鞏固臨床工作流程的整合提案。其他公司則專注於核心器械性能和卓越製造，投資於品質系統和先進材料工程，以確保臨床信心並降低再手術率。

競爭態勢也揭示了不同的智慧財產權和合作模式。與學術中心和科技公司的合作加速了創新週期，而選擇性收購則填補了電子、生物材料和軟體方面的能力缺口。優先事項還包括可製造的模組化設計、檢驗供應鏈中的可追溯性，以及建立監管路徑，以應對更嚴格的網路安全和人為因素標準。對於決策者而言，競爭優勢顯然將源於技術差異化、整合服務模式以及透過嚴謹的證據和上市後追蹤證明持續臨床價值的能力的結合。

為行業領導者提供切實可行的業務建議，以加速創新、最佳化供應鏈、加強合規性並快速改善以患者為中心的結果

行業領導者應優先考慮一系列切實可行的行動，以應對當前的挑戰並抓住新的機會。首先，協調研發和臨床證據項目，提供與臨床醫生和付款人產生共鳴的結果指標，確保設計選擇能夠預測實際使用情況和報銷標準。其次，透過多元化供應商、確定區域生產合作夥伴以及實施庫存緩衝策略來增強供應鏈的彈性，以減輕關稅和物流衝擊。第三，投資可互通的數位平台和安全遙測技術，以增強設備的價值提案，並滿足人們對遠端監控和網路安全日益成長的期望。

此外，我們正在透過試驗計畫、外科醫生培訓和風險分擔安排深化與醫療服務提供者網路的合作，以加速應用並產生可操作的真實世界數據。我們正在修訂定價和合約策略，以反映護理總成本和長期療效效益，而不僅僅是單位成本。最後，我們正在將監管策略整合到早期設計決策中，以縮短核准時間並簡化上市後義務。共同實施這些建議將打造一條從創新到部署的一致路徑，在速度、合規性和臨床影響之間取得平衡。

嚴謹的調查方法，闡明資料來源、相關人員參與、定性和定量檢驗步驟以及分析框架

本報告背後的調查方法結合了系統性證據收集、相關人員參與和交叉檢驗，以確保研究結果可靠且可操作。主要資訊包括對臨床醫生、採購負責人和技術專家的結構化訪談，以及手術現場訪問，以觀察工作流程互動和器械操作注意事項。次要資訊包括同行評審的臨床文獻、監管指導文件和技術標準，這些資料為材料性能、安全注意事項和生命週期管理實踐的評估提供了參考。

分析步驟將定性洞察與針對特定設備和應用的技術評估相結合，以識別關鍵成功因素和應用障礙。檢驗透過相關人員觀點以及與包含獨立臨床顧問的審查委員會的三角檢驗進行。自始至終，我們高度重視資料來源、調查方法和資料來源的透明度以及利益衝突的揭露，從而鞏固了結論的可信度。這種多層次的方法確保了建議既基於臨床現實，又基於技術可行性，從而能夠切實轉化為策略舉措。

簡明結論綜合了戰略意義、新興風險載體以及臨床、製造和政策領域相關人員的優先行動

結論部分總結了參與植入式器械開發、商業化和採購的利害關係人的策略重點。雖然新技術和材料科學的進步拓展了臨床應用的可能性，但從創新到持續應用的道路取決於整合策略，該策略將臨床證據、監管預見性和供應鏈穩健性相結合。相關人員必須在上市速度與全面的風險管理之間取得平衡，尤其是網路安全、上市後監管和人為因素。

務實而言，整合產品設計、臨床參與和商業性規劃的組織將更有能力確保產品的持久應用，並為患者帶來可衡量的益處。報告強調了區域戰略、有針對性的細分市場和合作夥伴關係關係對於克服成本壓力和政策主導的複雜性的重要性。透過將這些策略洞察轉化為優先行動計劃，領導者可以抓住機遇，減少實施阻力，並改善臨床環境中的療效。

目錄

第1章：前言

第2章調查方法

第3章執行摘要

第4章 市場概況

第5章 市場洞察

  • 由於可生物分解和可生物吸收植入物的普及，修復手術減少
  • 在心律調節器和神經刺激設備中整合無線連接和遠端監控
  • 微型化的進步使得微創心臟和神經植入成為可能
  • 下一代MRI相容植入整形外科器械獲得監管部門核准，擴大患者使用範圍
  • 利用人工智慧演算法個人化調整深部腦刺激參數
  • 封閉回路型連續血糖監測智慧胰島素幫浦的研製
  • 植入採用抗菌奈米技術塗層，以降低術後感染的風險

第6章：2025年美國關稅的累積影響

第7章：人工智慧的累積影響，2025年

第8章植入式醫療設備市場（依產品類型）

  • 心臟植入
    • 去心房顫動
    • 心律調節器
  • 美容植入
    • 乳房植入
    • 臉部植入
  • 人工植牙
  • 神經植入
  • 眼科植入
  • 整形外科植入
    • 髖關節植入
    • 膝關節植入

第9章植入式醫療設備市場（依材料）

  • 陶瓷製品
  • 金屬
  • 聚合物

第 10 章植入式醫療設備市場（依應用）

  • 心臟病學
  • 整容手術
  • 牙科
  • 神經病學
  • 整形外科

第 11 章植入式醫療設備市場（依最終用戶）

  • 門診手術中心
  • 診所
  • 醫院

第12章植入式醫療設備市場（按地區）

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第13章植入式醫療設備市場（依類別）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第14章植入式醫療設備市場（依國家）

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第15章競爭格局

  • 2024年市佔率分析
  • 2024年FPNV定位矩陣
  • 競爭分析
    • 3M Company
    • Abbott Laboratories
    • Aleva Neurotherapeutics
    • Allergan Inc. by AbbVie Inc.
    • B. Braun Melsungen AG
    • BIOTRONIK SE & Co KG
    • Boston Scientific Corporation
    • Cochlear Ltd.
    • Conmed Corporation
    • Definitive Healthcare, LLC
    • Demant A/S
    • Dentsply Sirona Inc.
    • Edwards Lifesciences Corporation
    • Globus Medical, Inc.
    • Integra Lifesciences Holdings Corporation
    • Invibio Ltd.
    • Johnson & Johnson Services, Inc.
    • Koninklijke Philips NV
    • LivaNova plc
    • Medtronic PLC
    • Microport Scientific Corporation
    • NuVasive, Inc.
    • Smith & Nephew PLC
    • Sonova Holding AG
    • Sterling Medical Devices
    • Straumann AG
    • Stryker Corporation
    • Terumo Corporation
    • WL Gore & Associates, Inc.
    • Zhejiang Nuoerkang Neuroelectronic Technology Co., Ltd.
    • Zimmer Biomet Holdings, Inc.
Product Code: MRR-4355714631BF

The Implantable Medical Device Market is projected to grow by USD 146.56 billion at a CAGR of 7.36% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 82.99 billion
Estimated Year [2025] USD 88.78 billion
Forecast Year [2032] USD 146.56 billion
CAGR (%) 7.36%

Comprehensive strategic introduction that frames the intent, scope, stakeholder priorities, and major themes guiding executive decisions in implantable devices

This executive summary introduces a structured, evidence-driven perspective on the implantable medical device arena, intended to inform board-level strategy, product development priorities, and operational planning. It frames the principal themes that influence decision-making-technology convergence, regulatory complexity, procurement dynamics, and evolving clinical pathways-while highlighting the interplay between innovation and practical deployment challenges. The introduction situates readers to the report's analytical approach, clarifies intended audiences, and outlines how insights can be mobilized to support near-term program choices and longer-term portfolio rationalization.

By establishing a clear problem statement and defining the strategic questions addressed, the introduction creates a common baseline for interpretation. It emphasizes how clinical outcomes, supply chain structure, and reimbursement environments jointly determine adoption trajectories for implantable devices. Consequently, readers gain a precise orientation that links technical performance and material selection to institutional purchasing behavior and clinician acceptance, enabling more targeted follow-through across clinical, regulatory, and commercial functions.

Rapid transformative shifts and technology adoption dynamics reshaping clinical practice, regulatory approaches, and supply chain resilience across implantable medical innovations

The landscape for implantable devices is undergoing rapid transformation driven by technological innovation, intensified regulatory scrutiny, and evolving clinician expectations. Advanced materials and miniaturized electronics are enabling new classes of devices that blend sensing, actuation, and connectivity, while concurrent progress in imaging and surgical techniques is expanding the range of feasible interventions. At the same time, regulators are increasing emphasis on post-market surveillance, cyber-security requirements, and human factors validation, which elevates the importance of robust clinical evidence and lifecycle management.

Supply chain dynamics have shifted toward resilience and geographic diversification, prompting manufacturers to reconsider sourcing strategies and increase collaboration with contract manufacturers and specialized suppliers. Payer and provider ecosystems are demanding stronger proof of value and patient-centered outcomes, which in turn influences product design and commercialization plans. These converging shifts mean that companies must align R&D, regulatory, and market access functions more tightly than before, and they must adopt more agile operational models to translate technical advances into durable clinical adoption and sustainable commercial returns.

Assessment of the cumulative implications of United States tariff measures in 2025 on manufacturing, procurement strategies, cross-border collaboration, and device availability

Policy changes affecting cross-border trade and tariff regimes in 2025 have generated material implications for manufacturers, suppliers, and purchasers of implantable devices. Tariff adjustments have altered cost structures across global supply chains, prompting procurement teams to reassess sourcing geographies and to evaluate nearshoring or regional sourcing as alternatives to previously centralized models. These decisions affect supplier negotiations, inventory strategies, and the calculus for investing in local production capability versus maintaining global supplier relationships.

Consequently, companies are revisiting total landed cost analyses and supplier risk profiles to understand the cumulative impact on product availability and production lead times. Clinical providers are also reassessing tender cycles and device selection criteria to mitigate exposure to price volatility and potential disruptions. Beyond immediate operational changes, tariff-driven shifts are encouraging more strategic collaboration between manufacturers and health systems, including multi-year agreements and joint planning for capacity buffers. Through these responses, stakeholders aim to preserve clinical continuity while adapting commercial models to a more complex international trade environment.

Key segmentation insights that reveal differential demand patterns by product, material composition, clinical application, and end-user settings across care delivery environments

Segmentation insights reveal distinct demand profiles and development priorities across product types, materials, applications, and end-user settings that inform portfolio and go-to-market strategies. Product-level differentiation is pronounced: cardiac implants such as defibrillators and pacemakers require stringent reliability, long-term telemetry, and regulatory pathways that emphasize durability and remote monitoring; cosmetic implants including breast and facial implants prioritize biocompatible materials and aesthetic outcomes driven by patient preference and surgeon technique; dental implants interface directly with restorative workflows and demand precision materials and surface engineering to enhance osseointegration; neural implants require ultra-low latency electronics and hermetic packaging to support sensitive neurologic applications; ophthalmic implants must satisfy micro-scale tolerances and ophthalmologic safety standards; and orthopedic implants including hip and knee implants focus on load-bearing materials and proven surgical instrumentation. Materials segmentation-ceramic, metal, and polymer-shapes performance trade-offs for wear, corrosion resistance, imaging compatibility, and tissue response, influencing both device selection and clinical protocols. Application-based segmentation across cardiology, cosmetic procedures, dentistry, neurology, and orthopedics further guides clinical evidence development and reimbursement positioning because each application area presents unique outcome metrics and adoption pathways. End users-ambulatory surgical centers, clinics, and hospitals-exhibit differing procurement cycles, procedural volumes, and capital constraints, which together determine purchasing levers and service-support needs. Integrating these segmentation lenses enables more granular product-market fit decisions, prioritization of clinical trials, and tailored commercial models that reflect the operational realities of each care environment.

Strategic regional insights focusing on demand drivers, regulatory nuances, and adoption barriers across the Americas, Europe Middle East & Africa, and Asia-Pacific markets

Regional differences continue to exert substantial influence on regulatory processes, reimbursement pathways, and adoption timelines for implantable devices. The Americas market combines a mature clinical ecosystem with established reimbursement frameworks and high procedural volumes, making it attractive for premium devices that can demonstrate clear clinical and economic value. In contrast, Europe, Middle East & Africa presents a heterogeneous regulatory landscape where regional harmonization initiatives coexist with country-specific reimbursement processes, creating both opportunities for differentiated entry strategies and challenges in evidentiary alignment. Asia-Pacific demonstrates rapid infrastructure expansion, an increasing number of trained specialists, and government-led initiatives to upgrade healthcare capacity, which together support faster uptake of new surgical technologies, albeit with greater price sensitivity and variable regulatory timetables.

These regional dynamics have practical implications for regulatory submissions, post-market surveillance expectations, and commercial prioritization. Companies often sequence launches to align with reimbursement readiness and clinical champion availability, while tailoring messaging and pricing strategies to local procurement norms. Strategic regional partnerships and adaptive market access approaches are essential to balance global product standardization with local customization needs, enabling scalable yet regionally effective deployment plans.

Competitive company-level insights highlighting strategic portfolios, collaboration networks, intellectual property focus, and operational priorities among leading device manufacturers

Leading companies in the implantable device ecosystem are differentiating through strategic portfolio choices, alliances, and operational investments that emphasize lifecycle management and clinical evidence generation. Some manufacturers are deepening capabilities in adjacent service offerings-such as remote monitoring platforms, data analytics for post-market surveillance, and surgeon training solutions-to create integrated propositions that improve patient outcomes and lock in clinical workflows. Others concentrate on core device performance and manufacturing excellence, investing in quality systems and advanced materials engineering to secure clinical trust and reduce revision rates.

Competitive dynamics also reveal varied approaches to intellectual property and collaborative models: partnerships with academic centers and technology firms accelerate innovation cycles, while selective acquisitions fill capability gaps in electronics, biomaterials, or software. Operational priorities include modular design for manufacturability, validation of supply chain traceability, and building regulatory pathways that anticipate tightening standards for cybersecurity and human factors. For decision-makers, the implication is clear: competitive advantage now stems from a blend of technical differentiation, integrated service models, and the ability to demonstrate sustained clinical value through rigorous evidence and post-market follow-up.

Actionable, operational recommendations for industry leaders to accelerate innovation, optimize supply chains, strengthen compliance, and enhance patient-centric outcomes rapidly

Industry leaders should prioritize a set of pragmatic, executable actions to navigate current headwinds while capturing emerging opportunities. First, align R&D and clinical evidence programs to deliver outcome measures that resonate with both clinicians and payers, ensuring that design choices anticipate real-world use conditions and reimbursement criteria. Second, strengthen supply chain resilience by diversifying suppliers, qualifying regional production partners, and implementing inventory-buffer strategies that mitigate tariff and logistics shocks. Third, invest in interoperable digital platforms and secure telemetry to enhance device value propositions and meet rising expectations for remote monitoring and cybersecurity.

Additionally, foster deeper collaboration with provider networks through pilot programs, surgeon training, and shared risk arrangements that accelerate adoption and generate practical real-world data. Reassess pricing and contracting strategies to reflect total cost of care and long-term outcome benefits rather than unit price alone. Finally, integrate regulatory strategy into early-stage design decisions to reduce time to approval and simplify post-market obligations. Executed together, these recommendations create a cohesive pathway from innovation to deployment that balances speed, compliance, and clinical impact.

Rigorous research methodology delineating data sourcing, stakeholder engagement, qualitative and quantitative validation steps, and analytical frameworks

The research methodology underpinning this report combines systematic evidence collection, stakeholder engagement, and cross-validation to ensure robust, actionable findings. Primary inputs included structured interviews with clinicians, procurement leaders, and technical experts, alongside site visits to procedural settings to observe workflow interactions and device handling considerations. Secondary inputs comprised peer-reviewed clinical literature, regulatory guidance documents, and technical standards that informed assessment of material performance, safety considerations, and lifecycle management practices.

Analytical steps involved synthesis of qualitative insights with device- and application-specific technical assessments to identify critical success factors and adoption barriers. Validation occurred through triangulation of stakeholder perspectives and review panels with independent clinical advisors. Throughout, an emphasis on transparency in data sources, methodological assumptions, and conflict-of-interest disclosures supports the credibility of conclusions. This layered methodology ensures that recommendations are grounded in both clinical reality and technical feasibility, enabling pragmatic translation into strategic initiatives.

Concise conclusion synthesizing strategic implications, emergent risk vectors, and priority actions for stakeholders across clinical, manufacturing, and policy domains

The concluding synthesis draws together strategic imperatives for stakeholders engaged in implantable device development, commercialization, and procurement. Emerging technologies and material science advances expand clinical possibilities, but the pathway from innovation to sustained adoption depends on integrated strategies that combine clinical evidence, regulatory foresight, and supply chain robustness. Stakeholders must balance speed-to-market with comprehensive risk management-particularly in areas such as cybersecurity, post-market surveillance, and human factors-because these domains increasingly govern regulatory acceptability and clinician confidence.

In practical terms, organizations that unify product design, clinical engagement, and commercial planning will be better positioned to secure durable adoption and deliver measurable patient benefits. The report underscores the importance of regional strategy, targeted segmentation, and collaborative partnerships to overcome cost pressures and policy-driven complexities. By translating these strategic insights into prioritized action plans, leaders can reduce implementation friction and seize opportunities to improve outcomes across clinical settings.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Rising adoption of biodegradable and bioresorbable implantable devices reducing revision surgeries
  • 5.2. Integration of wireless connectivity and remote monitoring in pacemakers and neurostimulators
  • 5.3. Advancements in miniaturization enabling minimally invasive cardiac and neural implants
  • 5.4. Regulatory approval of next-generation MRI-safe implantable orthopedic devices expanding patient access
  • 5.5. Use of artificial intelligence algorithms for personalized adjustment of deep brain stimulation parameters
  • 5.6. Development of smart insulin pumps with closed loop continuous glucose monitoring functionality
  • 5.7. Adoption of antimicrobial nanotechnology coatings on implants to reduce post operative infection risks

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Implantable Medical Device Market, by Product Type

  • 8.1. Cardiac Implants
    • 8.1.1. Defibrillator
    • 8.1.2. Pacemaker
  • 8.2. Cosmetic Implants
    • 8.2.1. Breast Implants
    • 8.2.2. Facial Implants
  • 8.3. Dental Implants
  • 8.4. Neural Implants
  • 8.5. Ophthalmic Implants
  • 8.6. Orthopedic Implants
    • 8.6.1. Hip Implants
    • 8.6.2. Knee Implants

9. Implantable Medical Device Market, by Material

  • 9.1. Ceramic
  • 9.2. Metal
  • 9.3. Polymer

10. Implantable Medical Device Market, by Application

  • 10.1. Cardiology
  • 10.2. Cosmetic Procedures
  • 10.3. Dentistry
  • 10.4. Neurology
  • 10.5. Orthopedics

11. Implantable Medical Device Market, by End User

  • 11.1. Ambulatory Surgical Centers
  • 11.2. Clinics
  • 11.3. Hospitals

12. Implantable Medical Device Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Implantable Medical Device Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Implantable Medical Device Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. Competitive Landscape

  • 15.1. Market Share Analysis, 2024
  • 15.2. FPNV Positioning Matrix, 2024
  • 15.3. Competitive Analysis
    • 15.3.1. 3M Company
    • 15.3.2. Abbott Laboratories
    • 15.3.3. Aleva Neurotherapeutics
    • 15.3.4. Allergan Inc. by AbbVie Inc.
    • 15.3.5. B. Braun Melsungen AG
    • 15.3.6. BIOTRONIK SE & Co KG
    • 15.3.7. Boston Scientific Corporation
    • 15.3.8. Cochlear Ltd.
    • 15.3.9. Conmed Corporation
    • 15.3.10. Definitive Healthcare, LLC
    • 15.3.11. Demant A/S
    • 15.3.12. Dentsply Sirona Inc.
    • 15.3.13. Edwards Lifesciences Corporation
    • 15.3.14. Globus Medical, Inc.
    • 15.3.15. Integra Lifesciences Holdings Corporation
    • 15.3.16. Invibio Ltd.
    • 15.3.17. Johnson & Johnson Services, Inc.
    • 15.3.18. Koninklijke Philips N.V.
    • 15.3.19. LivaNova plc
    • 15.3.20. Medtronic PLC
    • 15.3.21. Microport Scientific Corporation
    • 15.3.22. NuVasive, Inc.
    • 15.3.23. Smith & Nephew PLC
    • 15.3.24. Sonova Holding AG
    • 15.3.25. Sterling Medical Devices
    • 15.3.26. Straumann AG
    • 15.3.27. Stryker Corporation
    • 15.3.28. Terumo Corporation
    • 15.3.29. W. L. Gore & Associates, Inc.
    • 15.3.30. Zhejiang Nuoerkang Neuroelectronic Technology Co., Ltd.
    • 15.3.31. Zimmer Biomet Holdings, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY MATERIAL, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY MATERIAL, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 11. AMERICAS IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. NORTH AMERICA IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. LATIN AMERICA IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. EUROPE, MIDDLE EAST & AFRICA IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. EUROPE IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. MIDDLE EAST IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. AFRICA IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. ASEAN IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. GCC IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. EUROPEAN UNION IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. BRICS IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. G7 IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. NATO IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. IMPLANTABLE MEDICAL DEVICE MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 28. IMPLANTABLE MEDICAL DEVICE MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. IMPLANTABLE MEDICAL DEVICE MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY CARDIAC IMPLANTS, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY CARDIAC IMPLANTS, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY CARDIAC IMPLANTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY CARDIAC IMPLANTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY CARDIAC IMPLANTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY CARDIAC IMPLANTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY CARDIAC IMPLANTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY CARDIAC IMPLANTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY DEFIBRILLATOR, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY DEFIBRILLATOR, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY DEFIBRILLATOR, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY DEFIBRILLATOR, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY DEFIBRILLATOR, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY DEFIBRILLATOR, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY PACEMAKER, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY PACEMAKER, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY PACEMAKER, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY PACEMAKER, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY PACEMAKER, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY PACEMAKER, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY COSMETIC IMPLANTS, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY COSMETIC IMPLANTS, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY COSMETIC IMPLANTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY COSMETIC IMPLANTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY COSMETIC IMPLANTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY COSMETIC IMPLANTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY COSMETIC IMPLANTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY COSMETIC IMPLANTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY BREAST IMPLANTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY BREAST IMPLANTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY BREAST IMPLANTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY BREAST IMPLANTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY BREAST IMPLANTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY BREAST IMPLANTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY FACIAL IMPLANTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY FACIAL IMPLANTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY FACIAL IMPLANTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY FACIAL IMPLANTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY FACIAL IMPLANTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY FACIAL IMPLANTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY DENTAL IMPLANTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY DENTAL IMPLANTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY DENTAL IMPLANTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY DENTAL IMPLANTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY DENTAL IMPLANTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY DENTAL IMPLANTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY NEURAL IMPLANTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY NEURAL IMPLANTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY NEURAL IMPLANTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY NEURAL IMPLANTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY NEURAL IMPLANTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY NEURAL IMPLANTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY OPHTHALMIC IMPLANTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY OPHTHALMIC IMPLANTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY OPHTHALMIC IMPLANTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY OPHTHALMIC IMPLANTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY OPHTHALMIC IMPLANTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY OPHTHALMIC IMPLANTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY ORTHOPEDIC IMPLANTS, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY ORTHOPEDIC IMPLANTS, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY ORTHOPEDIC IMPLANTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY ORTHOPEDIC IMPLANTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY ORTHOPEDIC IMPLANTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY ORTHOPEDIC IMPLANTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY ORTHOPEDIC IMPLANTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY ORTHOPEDIC IMPLANTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY HIP IMPLANTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY HIP IMPLANTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY HIP IMPLANTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY HIP IMPLANTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY HIP IMPLANTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY HIP IMPLANTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY KNEE IMPLANTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY KNEE IMPLANTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY KNEE IMPLANTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY KNEE IMPLANTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY KNEE IMPLANTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY KNEE IMPLANTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY CERAMIC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY CERAMIC, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY CERAMIC, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY CERAMIC, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY CERAMIC, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY CERAMIC, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY METAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY METAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY METAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY METAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY METAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY METAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY POLYMER, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY POLYMER, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY POLYMER, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY POLYMER, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY POLYMER, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY POLYMER, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY CARDIOLOGY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY CARDIOLOGY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY CARDIOLOGY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY CARDIOLOGY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY CARDIOLOGY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY CARDIOLOGY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY COSMETIC PROCEDURES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY COSMETIC PROCEDURES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY COSMETIC PROCEDURES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY COSMETIC PROCEDURES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY COSMETIC PROCEDURES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY COSMETIC PROCEDURES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY DENTISTRY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY DENTISTRY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY DENTISTRY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY DENTISTRY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY DENTISTRY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY DENTISTRY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY NEUROLOGY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY NEUROLOGY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY NEUROLOGY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY NEUROLOGY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY NEUROLOGY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY ORTHOPEDICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY ORTHOPEDICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY ORTHOPEDICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY ORTHOPEDICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY ORTHOPEDICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY ORTHOPEDICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY CLINICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY CLINICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY CLINICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY CLINICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY CLINICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 157. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 158. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 159. AMERICAS IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 160. AMERICAS IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 161. AMERICAS IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 162. AMERICAS IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 163. AMERICAS IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY CARDIAC IMPLANTS, 2018-2024 (USD MILLION)
  • TABLE 164. AMERICAS IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY CARDIAC IMPLANTS, 2025-2032 (USD MILLION)
  • TABLE 165. AMERICAS IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY COSMETIC IMPLANTS, 2018-2024 (USD MILLION)
  • TABLE 166. AMERICAS IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY COSMETIC IMPLANTS, 2025-2032 (USD MILLION)
  • TABLE 167. AMERICAS IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY ORTHOPEDIC IMPLANTS, 2018-2024 (USD MILLION)
  • TABLE 168. AMERICAS IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY ORTHOPEDIC IMPLANTS, 2025-2032 (USD MILLION)
  • TABLE 169. AMERICAS IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 170. AMERICAS IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 171. AMERICAS IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 172. AMERICAS IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 173. AMERICAS IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 174. AMERICAS IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 175. NORTH AMERICA IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 176. NORTH AMERICA IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 177. NORTH AMERICA IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 178. NORTH AMERICA IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 179. NORTH AMERICA IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY CARDIAC IMPLANTS, 2018-2024 (USD MILLION)
  • TABLE 180. NORTH AMERICA IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY CARDIAC IMPLANTS, 2025-2032 (USD MILLION)
  • TABLE 181. NORTH AMERICA IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY COSMETIC IMPLANTS, 2018-2024 (USD MILLION)
  • TABLE 182. NORTH AMERICA IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY COSMETIC IMPLANTS, 2025-2032 (USD MILLION)
  • TABLE 183. NORTH AMERICA IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY ORTHOPEDIC IMPLANTS, 2018-2024 (USD MILLION)
  • TABLE 184. NORTH AMERICA IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY ORTHOPEDIC IMPLANTS, 2025-2032 (USD MILLION)
  • TABLE 185. NORTH AMERICA IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 186. NORTH AMERICA IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 187. NORTH AMERICA IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 188. NORTH AMERICA IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 189. NORTH AMERICA IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 190. NORTH AMERICA IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 191. LATIN AMERICA IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 192. LATIN AMERICA IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 193. LATIN AMERICA IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 194. LATIN AMERICA IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 195. LATIN AMERICA IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY CARDIAC IMPLANTS, 2018-2024 (USD MILLION)
  • TABLE 196. LATIN AMERICA IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY CARDIAC IMPLANTS, 2025-2032 (USD MILLION)
  • TABLE 197. LATIN AMERICA IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY COSMETIC IMPLANTS, 2018-2024 (USD MILLION)
  • TABLE 198. LATIN AMERICA IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY COSMETIC IMPLANTS, 2025-2032 (USD MILLION)
  • TABLE 199. LATIN AMERICA IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY ORTHOPEDIC IMPLANTS, 2018-2024 (USD MILLION)
  • TABLE 200. LATIN AMERICA IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY ORTHOPEDIC IMPLANTS, 2025-2032 (USD MILLION)
  • TABLE 201. LATIN AMERICA IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 202. LATIN AMERICA IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 203. LATIN AMERICA IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 204. LATIN AMERICA IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 205. LATIN AMERICA IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 206. LATIN AMERICA IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 207. EUROPE, MIDDLE EAST & AFRICA IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 208. EUROPE, MIDDLE EAST & AFRICA IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 209. EUROPE, MIDDLE EAST & AFRICA IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 210. EUROPE, MIDDLE EAST & AFRICA IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 211. EUROPE, MIDDLE EAST & AFRICA IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY CARDIAC IMPLANTS, 2018-2024 (USD MILLION)
  • TABLE 212. EUROPE, MIDDLE EAST & AFRICA IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY CARDIAC IMPLANTS, 2025-2032 (USD MILLION)
  • TABLE 213. EUROPE, MIDDLE EAST & AFRICA IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY COSMETIC IMPLANTS, 2018-2024 (USD MILLION)
  • TABLE 214. EUROPE, MIDDLE EAST & AFRICA IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY COSMETIC IMPLANTS, 2025-2032 (USD MILLION)
  • TABLE 215. EUROPE, MIDDLE EAST & AFRICA IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY ORTHOPEDIC IMPLANTS, 2018-2024 (USD MILLION)
  • TABLE 216. EUROPE, MIDDLE EAST & AFRICA IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY ORTHOPEDIC IMPLANTS, 2025-2032 (USD MILLION)
  • TABLE 217. EUROPE, MIDDLE EAST & AFRICA IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 218. EUROPE, MIDDLE EAST & AFRICA IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 219. EUROPE, MIDDLE EAST & AFRICA IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 220. EUROPE, MIDDLE EAST & AFRICA IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 221. EUROPE, MIDDLE EAST & AFRICA IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 222. EUROPE, MIDDLE EAST & AFRICA IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 223. EUROPE IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 224. EUROPE IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 225. EUROPE IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 226. EUROPE IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 227. EUROPE IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY CARDIAC IMPLANTS, 2018-2024 (USD MILLION)
  • TABLE 228. EUROPE IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY CARDIAC IMPLANTS, 2025-2032 (USD MILLION)
  • TABLE 229. EUROPE IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY COSMETIC IMPLANTS, 2018-2024 (USD MILLION)
  • TABLE 230. EUROPE IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY COSMETIC IMPLANTS, 2025-2032 (USD MILLION)
  • TABLE 231. EUROPE IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY ORTHOPEDIC IMPLANTS, 2018-2024 (USD MILLION)
  • TABLE 232. EUROPE IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY ORTHOPEDIC IMPLANTS, 2025-2032 (USD MILLION)
  • TABLE 233. EUROPE IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 234. EUROPE IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 235. EUROPE IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 236. EUROPE IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 237. EUROPE IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 238. EUROPE IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 239. MIDDLE EAST IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 240. MIDDLE EAST IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 241. MIDDLE EAST IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 242. MIDDLE EAST IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 243. MIDDLE EAST IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY CARDIAC IMPLANTS, 2018-2024 (USD MILLION)
  • TABLE 244. MIDDLE EAST IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY CARDIAC IMPLANTS, 2025-2032 (USD MILLION)
  • TABLE 245. MIDDLE EAST IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY COSMETIC IMPLANTS, 2018-2024 (USD MILLION)
  • TABLE 246. MIDDLE EAST IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY COSMETIC IMPLANTS, 2025-2032 (USD MILLION)
  • TABLE 247. MIDDLE EAST IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY ORTHOPEDIC IMPLANTS, 2018-2024 (USD MILLION)
  • TABLE 248. MIDDLE EAST IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY ORTHOPEDIC IMPLANTS, 2025-2032 (USD MILLION)
  • TABLE 249. MIDDLE EAST IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 250. MIDDLE EAST IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 251. MIDDLE EAST IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 252. MIDDLE EAST IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 253. MIDDLE EAST IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 254. MIDDLE EAST IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 255. AFRICA IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 256. AFRICA IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 257. AFRICA IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 258. AFRICA IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 259. AFRICA IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY CARDIAC IMPLANTS, 2018-2024 (USD MILLION)
  • TABLE 260. AFRICA IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY CARDIAC IMPLANTS, 2025-2032 (USD MILLION)
  • TABLE 261. AFRICA IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY COSMETIC IMPLANTS, 2018-2024 (USD MILLION)
  • TABLE 262. AFRICA IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY COSMETIC IMPLANTS, 2025-2032 (USD MILLION)
  • TABLE 263. AFRICA IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY ORTHOPEDIC IMPLANTS, 2018-2024 (USD MILLION)
  • TABLE 264. AFRICA IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY ORTHOPEDIC IMPLANTS, 2025-2032 (USD MILLION)
  • TABLE 265. AFRICA IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 266. AFRICA IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 267. AFRICA IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 268. AFRICA IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 269. AFRICA IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 270. AFRICA IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 271. ASIA-PACIFIC IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 272. ASIA-PACIFIC IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 273. ASIA-PACIFIC IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 274. ASIA-PACIFIC IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 275. ASIA-PACIFIC IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY CARDIAC IMPLANTS, 2018-2024 (USD MILLION)
  • TABLE 276. ASIA-PACIFIC IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY CARDIAC IMPLANTS, 2025-2032 (USD MILLION)
  • TABLE 277. ASIA-PACIFIC IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY COSMETIC IMPLANTS, 2018-2024 (USD MILLION)
  • TABLE 278. ASIA-PACIFIC IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY COSMETIC IMPLANTS, 2025-2032 (USD MILLION)
  • TABLE 279. ASIA-PACIFIC IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY ORTHOPEDIC IMPLANTS, 2018-2024 (USD MILLION)
  • TABLE 280. ASIA-PACIFIC IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY ORTHOPEDIC IMPLANTS, 2025-2032 (USD MILLION)
  • TABLE 281. ASIA-PACIFIC IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 282. ASIA-PACIFIC IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 283. ASIA-PACIFIC IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 284. ASIA-PACIFIC IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 285. ASIA-PACIFIC IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 286. ASIA-PACIFIC IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 287. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 288. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 289. ASEAN IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 290. ASEAN IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 291. ASEAN IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 292. ASEAN IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 293. ASEAN IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY CARDIAC IMPLANTS, 2018-2024 (USD MILLION)
  • TABLE 294. ASEAN IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY CARDIAC IMPLANTS, 2025-2032 (USD MILLION)
  • TABLE 295. ASEAN IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY COSMETIC IMPLANTS, 2018-2024 (USD MILLION)
  • TABLE 296. ASEAN IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY COSMETIC IMPLANTS, 2025-2032 (USD MILLION)
  • TABLE 297. ASEAN IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY ORTHOPEDIC IMPLANTS, 2018-2024 (USD MILLION)
  • TABLE 298. ASEAN IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY ORTHOPEDIC IMPLANTS, 2025-2032 (USD MILLION)
  • TABLE 299. ASEAN IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 300. ASEAN IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 301. ASEAN IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 302. ASEAN IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 303. ASEAN IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 304. ASEAN IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 305. GCC IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 306. GCC IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 307. GCC IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 308. GCC IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 309. GCC IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY C